Intratracheal immunization with pili protein protects against mortality associated withPseudomonas aeruginosapneumonia in mice
Open Access
- 1 June 2006
- journal article
- Published by Oxford University Press (OUP) in FEMS Immunology & Medical Microbiology
- Vol. 47 (1) , 107-115
- https://doi.org/10.1111/j.1574-695x.2006.00069.x
Abstract
We examined the protective effect of intratracheal immunization with Pseudomonas aeruginosa pili protein against respiratory infection caused by P. aeruginosa. Mice were immunized intratracheally or subcutaneously with purified pili protein or bovine serum albumin as a control. Intratracheally but not subcutaneously pili protein-immunized mice showed significant improvement of survival after intratracheal challenge with the PAO1 strain. Furthermore, bacterial cell counts in pili protein-immunized murine lungs were significantly decreased compared to controls at 18 h after the challenge. Antipili protein antibody titers in bronchoalveolar lavage fluid of intratracheally pili protein-immunized mice were higher than in bovine serum albumin immunized mice. However, antipili antibody titers were not increased in bronchoalveolar lavage fluid of subcutaneously pili protein-immunized mice, despite the high serum antipili antibody titers. Inoculation of P. aeruginosa induced immediate increases in interleukin-12 and interferon-γ in bronchoalveolar lavage fluid of pili protein-immunized mice, reflecting an adequate and rapid immune response against P. aeruginosa respiratory tract infection. Our findings suggest that intratracheal pili protein immunization is effective against respiratory tract infection caused by P. aeruginosa in mice.Keywords
This publication has 33 references indexed in Scilit:
- National Surveillance of Antimicrobial Resistance in Pseudomonas aeruginosa Isolates Obtained from Intensive Care Unit Patients from 1993 to 2002Antimicrobial Agents and Chemotherapy, 2004
- Results from the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) Programme: report of the 2001 data from 15 United States medical centresInternational Journal of Antimicrobial Agents, 2004
- Increased Protection against Pneumococcal Disease by Mucosal Administration of Conjugate Vaccine plus Interleukin-12Infection and Immunity, 2003
- Construction and Characterization of aPseudomonas aeruginosaMucoid Exopolysaccharide-Alginate Conjugate VaccineInfection and Immunity, 2003
- Intranasal Vaccination with Pneumococcal Surface Protein A and Interleukin-12 Augments Antibody-Mediated Opsonization and Protective Immunity againstStreptococcus pneumoniaeInfectionInfection and Immunity, 2001
- Nosocomial infections in medical intensive care units in the United StatesCritical Care Medicine, 1999
- Human immune response to a Pseudomonas aeruginosa outer membrane protein vaccineVaccine, 1999
- Functional diversity of helper T lymphocytesNature, 1996
- Diverse Pseudomonas aeruginosa gene products stimulate respiratory epithelial cells to produce interleukin-8.Journal of Clinical Investigation, 1995
- Experimental Studies of the Pathogenesis of Infections due to Pseudomonas aeruginosa: Immunization Using Divalent Flagella PreparationsPublished by Wolters Kluwer Health ,1986